CY1106632T1 - Μεθοδος ληψης παραγωγων [[(πυριδιλ υποκατεστημενου) μεθυλ] θειο] βενζιμιδαζολιου - Google Patents

Μεθοδος ληψης παραγωγων [[(πυριδιλ υποκατεστημενου) μεθυλ] θειο] βενζιμιδαζολιου

Info

Publication number
CY1106632T1
CY1106632T1 CY20071100725T CY071100725T CY1106632T1 CY 1106632 T1 CY1106632 T1 CY 1106632T1 CY 20071100725 T CY20071100725 T CY 20071100725T CY 071100725 T CY071100725 T CY 071100725T CY 1106632 T1 CY1106632 T1 CY 1106632T1
Authority
CY
Cyprus
Prior art keywords
methyl
pyridyl substituted
alkoxy
obtaining
benzimidazole derivatives
Prior art date
Application number
CY20071100725T
Other languages
English (en)
Inventor
Laura Coppi
Ramón BERENGUER MAIMO
Original Assignee
Esteve Quimica, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica, S.A. filed Critical Esteve Quimica, S.A.
Publication of CY1106632T1 publication Critical patent/CY1106632T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μια μέθοδο για τη λήψη παραγώγων [[(πυριδιλ υποκατεστημένου)μεθυλ]θειο]βενζιμιδαζολίου (I), όπου R1, R3 και R4 ανεξάρτητα αναπαριστούν υδρογόνο, αλκύλιο, αλκοξύ ή φθοριωμένο αλκοξύ με 1 έως 6 άτομα άνθρακα, R2 αναπαριστά άζωτο, αλογόνο, αλκοξύ ή αλογονωμένο αλκοξύ με 1 έως 6 άτομα άνθρακα ή μια -Ο-(CH2)n-OR8 ομάδα, όπου n είναι ένας ακέραιος αριθμός από 1 έως 6 και R8 αναπαριστά υδρογόνο ή μια αλκυλο ομάδα με 1 έως 6 άτομα άνθρακα. Η μέθοδος περιλαμβάνει τα ακόλουθα στάδια: (α) αντίδραση ενός Ν-οξειδίου μεθυλοπυριδίνης με έναν ανυδρίτη καρβοξυλικού οξέος ή σουλφονικού οξέος και (β) αντίδραση του ενδιάμεσου προϊόντος που διαμορφώνεται στο στάδιο (α) με ένα αντίστοιχο μερκαπτοβενζιμιδαζόλιο. Οι ενώσεις (I) είναι χρήσιμες για τη σύνθεση [[(πυριδιλ υποκατεστημένου)μεθυλ]θειο]βενζιμιδαζολίου, για παράδειγμα, ομεπραζόλη, λανσοπραζόλη, ραβεπραζόλη και παντοπραζόλη.
CY20071100725T 2000-04-14 2007-05-31 Μεθοδος ληψης παραγωγων [[(πυριδιλ υποκατεστημενου) μεθυλ] θειο] βενζιμιδαζολιου CY1106632T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000989A ES2171116B1 (es) 2000-04-14 2000-04-14 Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
PCT/ES2001/000143 WO2001079194A1 (es) 2000-04-14 2001-04-10 Procedimiento para la obtención de derivados de [[(piridil sustituido)metil]tio]bencimidazol

Publications (1)

Publication Number Publication Date
CY1106632T1 true CY1106632T1 (el) 2012-01-25

Family

ID=8493207

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100725T CY1106632T1 (el) 2000-04-14 2007-05-31 Μεθοδος ληψης παραγωγων [[(πυριδιλ υποκατεστημενου) μεθυλ] θειο] βενζιμιδαζολιου

Country Status (18)

Country Link
US (1) US6723852B2 (el)
EP (1) EP1411053B1 (el)
JP (1) JP2003531144A (el)
KR (1) KR100757346B1 (el)
CN (1) CN1214027C (el)
AT (1) ATE363479T1 (el)
AU (1) AU780314B2 (el)
CA (1) CA2405304C (el)
CY (1) CY1106632T1 (el)
DE (1) DE60128736T2 (el)
DK (1) DK1411053T3 (el)
ES (2) ES2171116B1 (el)
HU (1) HUP0300583A2 (el)
MX (1) MXPA02010039A (el)
NO (1) NO323468B1 (el)
NZ (1) NZ521930A (el)
PT (1) PT1411053E (el)
WO (1) WO2001079194A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185459B1 (es) 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
ES2245277T1 (es) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
EP1615913A2 (en) * 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
KR100771659B1 (ko) * 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
US20080262043A1 (en) * 2005-05-06 2008-10-23 Medichem, S.A. Solid Crystalline Form of Pantoprazole Free Acid, Salts Derived Therefrom and Process for Their Preparation
CN101400670B (zh) * 2006-03-10 2012-10-10 阿利健制药有限公司 具有抗幽门螺杆菌作用的吡啶衍生物
WO2008001392A2 (en) * 2006-06-30 2008-01-03 Msn Laboratories Limited An improved process for the preparation of pantoprazole and its pharmaceutically acceptable salts
ES2390611T3 (es) * 2006-12-18 2012-11-14 Arigen Pharmaceuticals, Inc. Agente de erradicación de Helicobacter pylori que tiene actividad inhibidora sobre la secreción de ácido gástrico
WO2009010937A1 (en) 2007-07-17 2009-01-22 Ranbaxy Laboratories Limited Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
US20090076089A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched pantoprazole
CN102020637B (zh) * 2010-12-13 2014-09-10 浙江华义医药有限公司 5-二氟甲氧基-2-[[(3,4-二甲氧基-2-吡啶基)甲基]硫基]-1h-苯并咪唑制备法
CN103242297A (zh) * 2013-05-20 2013-08-14 湖北宜恒茶油产业科技有限责任公司 一种5-二氟甲氧基-2-[[(4-氯-3-甲氧基-2-吡啶基)甲基]硫代]-1h-苯并咪唑一水合物的制备方法
CN103664886A (zh) * 2013-12-06 2014-03-26 威海迪素制药有限公司 2-[[[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基]硫代]-1h-苯并咪唑的制备方法
CN105399729B (zh) * 2015-12-21 2018-04-17 山东金城医药化工有限公司 奥美拉唑的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
ZA854287B (en) * 1984-06-16 1986-02-26 Byk Gulden Lomberg Chem Fab Dialkoxypyridines,process for their preparation,their use and medicaments containing them
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
JPH0674272B2 (ja) * 1986-11-13 1994-09-21 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2024357A6 (es) * 1990-12-05 1992-02-16 Genesis Para La Investigacion Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
KR960705811A (ko) * 1993-10-29 1996-11-08 고오야 다다시 피리딘 화합물 및 그의 약학적 용도[pyridine compound and medicinal use thereof]
JP3828648B2 (ja) * 1996-11-14 2006-10-04 武田薬品工業株式会社 ２−（２−ピリジルメチルスルフィニル）ベンズイミダゾール系化合物の結晶およびその製造法
ID18983A (id) * 1996-12-04 1998-05-28 Lilly Co Eli Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
GB9921578D0 (en) * 1999-09-13 1999-11-17 Cipla Limited Omeprazole synthesis

Also Published As

Publication number Publication date
NO323468B1 (no) 2007-05-21
MXPA02010039A (es) 2004-08-19
KR20030030990A (ko) 2003-04-18
NO20024858L (no) 2002-12-06
EP1411053A1 (en) 2004-04-21
CN1427836A (zh) 2003-07-02
HUP0300583A2 (hu) 2003-07-28
NZ521930A (en) 2004-07-30
ES2171116A1 (es) 2002-08-16
CA2405304A1 (en) 2002-10-07
AU780314B2 (en) 2005-03-17
ATE363479T1 (de) 2007-06-15
CN1214027C (zh) 2005-08-10
AU4655101A (en) 2001-10-30
CA2405304C (en) 2011-01-18
WO2001079194A1 (es) 2001-10-25
DE60128736D1 (de) 2007-07-12
US20030036656A1 (en) 2003-02-20
JP2003531144A (ja) 2003-10-21
PT1411053E (pt) 2007-07-12
DK1411053T3 (da) 2007-09-24
DE60128736T2 (de) 2008-02-07
ES2171116B1 (es) 2003-08-01
KR100757346B1 (ko) 2007-09-11
US6723852B2 (en) 2004-04-20
EP1411053B1 (en) 2007-05-30
ES2284629T3 (es) 2007-11-16
WO2001079194A9 (es) 2003-05-08
NO20024858D0 (no) 2002-10-08

Similar Documents

Publication Publication Date Title
CY1106632T1 (el) Μεθοδος ληψης παραγωγων [[(πυριδιλ υποκατεστημενου) μεθυλ] θειο] βενζιμιδαζολιου
HU9201459D0 (en) N-alkylene-piperidinone derivatives and process for the production of medical preparations containing them as active agents
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
CY1105197T1 (el) Μεθοδος παραγωγης σουλφοναμιδο-υποκατεστημενων ιμιδαζοτριαζινονων
DE60208683D1 (de) Verfahren zur herstellung von heterocyclischen pentalen derivaten
EE200400052A (et) Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning kõrvalsaadusena moodustunud sulfoonide eemaldamiseks
CY1108024T1 (el) Αλατα αλκυλαμμωνιου ομεπραζολης και εσομεπραζολης
EA200300151A1 (ru) ПРОИЗВОДНЫЕ 2-ПИРИДИНИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА И 7-ПИРИДИНИЛ-2,3-ДИГИДРОИМИДАЗО[1,2-a]ПИРИМИДИН-5(1H)ОНА
FI921473A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
ATE216382T1 (de) Verfahren zur herstellung von 5-methoxy-2-((4- methoxy-3,5-dimethyl-2-pyrydyl)methyl)sulfinyl- h-benzimidazol
KR860001810A (ko) 1,6-나프티리딘 유도체의 제조방법
CY1104998T1 (el) Εκδοχα 3-ετεροαρυλο-3,5-διϋδρο-4-οξο-4η-πυριδαζινο [4,5-b] ινδολο-1-ακεταμιδιου, η διαδικασια παρασκευης τους kai h εφαρμογη τους στην θεραπευτικη
DE3264253D1 (de) Pyridine derivatives as histamine h2 antagonists
TR200401671T1 (tr) Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi
DE60104719D1 (de) Verfahren zur herstellung von triphendioxazinpigmenten
DK1565441T3 (da) Fremgangsmåde til fremstilling af 2-aminomethylpyridinderivater
HUP0000366A2 (hu) Eljárás heterociklusos vegyületek előállítására
ATE277024T1 (de) Verfahren zur herstellung eines 4- thiazolylmethylderivates
ATE500241T1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
ATE315561T1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
HUP9701022A1 (hu) Eljárás[(5,6-dikarboxi-3-piridil)-metil]-ammónium-halogenid-származékok és ezekből herbicid hatású imidazolinonszármazékok előállítására
ATE191911T1 (de) Neue chinoloncarbonsäurederivate
ATE371646T1 (de) Verfahren zur herstellung optisch aktiver verbindungen
TH48283A (th) อนุพันธ์แลคแตม